Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Angstrom Pharmaceuticals Inc.
DescriptionAnti-angiogenic peptide derived from urokinase plasminogen activator (uPA)
Molecular Target
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today